IJCCR_2024v14n3

International Journal of Clinical Case Reports 2024, Vol.14, No.3, 144-156 http://medscipublisher.com/index.php/ijccr 155 Hall M., Cohen J., Ard J., Egan B., Hall J., Lavie C., Ma J., Ndumele C., Schauer P., and Shimbo D., 2021, Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the american heart association, Hypertension, 78: e38-e50. https://doi.org/10.1161/HYP.0000000000000202 PMid:34538096 Jia G., and Sowers J., 2021, Hypertension in diabetes: an update of basic mechanisms and clinical disease, Hypertension (Dallas, Tex. : 1979), 78: 1197-1205. https://doi.org/10.1161/HYPERTENSIONAHA.121.17981 PMid:34601960 PMCid:PMC8516748 Kissima T., Zoumana S., Modibo D., Salvador M., Ousmane T., Leon B., Salia T., Elie D., Drissa S., Malick B., and Adama K., 2018, Hypertensive heart disease, epidemiological, diagnostic and evolutionary aspects: about 103 cases in a cardiology department of sikasso hospital in mali, Cardiology and Vascular Research, 2(4): 1-4. https://doi.org/10.33425/2639-8486.1034 Kitt J., Fox R., Tucker K., and McManus R., 2019, New approaches in hypertension management: a review of current and developing technologies and their potential impact on hypertension care, Current Hypertension Reports, 21(6): 44. https://doi.org/10.1007/s11906-019-0949-4 PMid:31025117 PMCid:PMC6483962 Lauder L., Azizi M., Kirtane A., Böhm M., and Mahfoud F., 2020, Device-based therapies for arterial hypertension, Nature Reviews Cardiology, 17(10): 614-628. https://doi.org/10.1038/s41569-020-0364-1 Mahmood S., Shah K., Khan T., Nawaz S., Rashid H., Baqar S., and Kamran S., 2018, Non-pharmacological management of hypertension: in the light of current research, Irish Journal of Medical Science (1971 -), 188: 437-452. https://doi.org/10.1007/s11845-018-1889-8 PMid:30136222 Masenga S., and Kirabo A., 2023, Hypertensive heart disease: risk factors, complications and mechanisms, Frontiers in Cardiovascular Medicine, 10: 1205475. https://doi.org/10.3389/fcvm.2023.1205475 PMid:37342440 PMCid:PMC10277698 Meelab S., Bunupuradah I., Suttiruang J., Sakulrojanawong S., Thongkua N., Chantawiboonchai C., Chirabandhu P., Lertthanaporn S., Suwanthip K., Songsaengthum C., Keattisaksri B., Trakulsuk P., Pittapun A., Nata N., Rangsin R., and Sakboonyarat B., 2019, Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: a cross-sectional study, PLoS ONE, 14(2): e0212572. https://doi.org/10.1371/journal.pone.0212572 Mills K., Obst K., Shen W., Molina S., Zhang H., He H., Cooper L., and He J., 2018, Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients, Annals of Internal Medicine, 168: 110-120. https://doi.org/10.7326/M17-1805 PMid:29277852 PMCid:PMC5788021 Mills K., Stefanescu A., and He J., 2020, The global epidemiology of hypertension, Nature Reviews Nephrology, 16: 223-237. https://doi.org/10.1038/s41581-019-0244-2 PMid:32024986 PMCid:PMC7998524 Nandi S., Katsurada K., Mahata S., and Patel K., 2021, Neurogenic hypertension mediated mitochondrial abnormality leads to cardiomyopathy: contribution of uprmt and norepinephrine-miR- 18a-5p-HIF-1α axis, Frontiers in Physiology, 12: 718982. https://doi.org/10.3389/fphys.2021.718982 PMid:34912235 PMCid:PMC8667690 Nwabuo C., and Vasan R., 2020, Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy, Current Hypertension Reports, 22: 1-18. https://doi.org/10.1007/s11906-020-1017-9 PMid:32016791 Pinho-Gomes A. C., and Rahimi K., 2019, Management of blood pressure in heart failure, Heart, 105(8): 589-595. https://doi.org/10.1136/heartjnl-2018-314438 PMid:30674544 Pugh D., Gallacher P., and Dhaun N., 2019, Management of hypertension in chronic kidney disease, Drugs, 79: 365-379. https://doi.org/10.1007/s40265-019-1064-1 PMid:30758803 PMCid:PMC6422950 Rea F., Corrao G., Merlino L., and Mancia G., 2018, Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension, European Heart Journal, 39: 3654-3661. https://doi.org/10.1093/eurheartj/ehy420 PMid:30060044 Saeed S., Tadic M., Grytaas M., Mancia G., and Larsen T., 2020, The value of multimodality imaging in hypertensive heart disease, Journal of Hypertension, 39(5): 1040-1043. https://doi.org/10.1097/HJH.0000000000002726 PMid:33239554

RkJQdWJsaXNoZXIy MjQ4ODYzNQ==